Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Atf6α deficiency suppresses microglial activation and ameliorates pathology of experimental autoimmune encephalomyelitis.
Role of IL-17-producing lymphocytes in severity of multiple sclerosis upon natalizumab treatment.
[Cell depletion and myoablation for neuroimmunological diseases].
Safety of switching from natalizumab straight into fingolimod in a group of JCV-positive patients with multiple sclerosis.
Tuning PAK Activity to Rescue Abnormal Myelin Permeability in HNPP.
Discontinuation of disease-modifying therapies in multiple sclerosis - Clinical outcome and prognostic factors.
Concomitant Use of Neuroprotective Drugs in Neuro Rehabilitation of Multiple Sclerosis.
A Risk Score for Predicting Multiple Sclerosis.
Non-Gaussian Diffusion Imaging Shows Brain Myelin and Axonal Changes in Obstructive Sleep Apnea.
Pseudo-Foster Kennedy Syndrome as a Rare Presentation of Vitamin B12 Deficiency.
Efficient presentation of myelin oligodendrocyte glycoprotein peptides but not protein by astrocytes from HLA-DR2 and HLA-DR4 transgenic mice.
Development of rheumatoid arthritis during treatment of multiple sclerosis with interferon beta 1-a. Coincidence of two conditions or a complication of treatment: A case report.
Sick leave and disability pension before and after diagnosis of multiple sclerosis.
From trash to treasure: The untapped potential of endothelial microparticles in neurovascular diseases.
Neonatal Bacillus Calmette-Guérin vaccination alleviates lipopolysaccharide-induced neurobehavioral impairments and neuroinflammation in adult mice.
Disulfiram and Diphenhydramine Hydrochloride Upregulate miR-30a to Suppress IL-17-Associated Autoimmune Inflammation.
Successful surgical treatment of scoliosis secondary to Guillain-Barré syndrome: Case report.
Is Season of Birth Important for Multiple Sclerosis Risk?
[Endogenous retroviruses are associated with autoimmune diseases].
Upregulation of CD4+T-Cell Derived MiR-223 in The Relapsing Phase of Multiple Sclerosis Patients.
Bone And Soft Tissue Changes In Patients With Spinal Cord Injury And Multiple Sclerosis.
Comment on Evaluation of Choroidal Vascular Changes in Patients with Multiple Sclerosis Using Enhanced Depth Imaging Optical Coherence Tomography.
Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis.
New oral drugs for the treatment of multiple sclerosis.
Stereotactic injection of shrna GSK-3β-AAV promotes axonal regeneration after spinal cord injury.
Pages
« first
‹ previous
…
775
776
777
778
779
780
781
782
783
…
next ›
last »